Company news
HemoGenyx Pharmaceuticals PLC news in 2023
HemoGenyx Pharmaceuticals PLC's news releases, calls and decks from 2023, newest first.
Placing to Raise £534,375
November 28, 2023
CBR Expanded to Treatment of Cancer
November 27, 2023
Lentivirus Re-manufacturing Completed
November 15, 2023
Hemogenyx Pharmaceuticals Announces Strategic Investment from Prevail Partners, LLC
September 19, 2023
Clinical Hold Lift Plan is accepted by FDA
September 14, 2023
CBR Patent Application Update
September 8, 2023
Full FDA Review for HEMO-CAR-T IND
July 10, 2023
Clinical Hold on IND for HEMO-CAR-T
June 2, 2023
Submission of IND for HEMO-CAR-T
May 9, 2023
Equity Incentive Pool Increase and Option Grant
April 28, 2023
HEMO-CAR-T Analytical Release Tests Completed
March 23, 2023
Admission of Shares to Official List
February 7, 2023
Second Price Monitoring Extn
January 26, 2023
HEMO-CAR-T 3rd Process Qualification Run Completed
January 23, 2023
Price Monitoring Extension
January 16, 2023
Single CBR Can Treat Multiple Viruses
January 9, 2023